Comparison of Three Technical Airway Clearance in Mechanical Ventilated Patients (ClearanceMV)

November 11, 2015 updated by: Hospital de Clinicas de Porto Alegre
Randomized clinical trial, conducted in the Intensive Care Unit of the Hospital de Clinicas de Porto Alegre from october 2011 until november 2015 .

Study Overview

Detailed Description

Objective: To compare the effectiveness of techniques: vibrocompression (G1), hyperinflation with mechanical ventilation (G2) vibrocompression + hyperinflation with mechanical ventilation (G3) in the amount of aspirated secretions, mechanical ventilator time, incidence of ventilator-associated pneumonia , reintubation tracheal and mortality in mechanical ventilator. Primary outcome: weight in grams of the aspirated secretions. Secondary outcome: hemodynamic and pulmonary parameters: heart rate, respiratory rate, mean arterial pressure, peripheral arterial oxygen saturation; peak inspiratory pressure, tidal volume; dynamic compliance ; mechanical ventilator time; reintubation tracheal; Incidence of ventilator-associated pneumonia and mortality in mechanical ventilator.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • In mechanical ventilation for a period of 24-72 h
  • End-expiratory pressure (PEEP) lower 10 cm of water.
  • Lower noradrenaline doses of 0.5mg / kg / minute for an average greater than or equal blood outstrips 60 mmHg.

Exclusion Criteria:

  • Pneumothorax and hemothorax undrained
  • Subcutaneous emphysema
  • Osteoporosis
  • Acute respiratory distress syndrome - (ARDS)
  • Fractures of ribs
  • Obese ( BMI greater than 35)
  • Mechanical ventilator with higher peak pressures 40 cm of water.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Vibocompression (VB)
Grup 1 - Vibrocompression: Is a physical therapy technique, that aims to clear the airways of patients on mechanical ventilation. Through the thoracic compression during expiration
Vibrocompression is a physical therapy technique, that aims to clear the airways of patients on mechanical ventilation (MV)
Other Names:
  • Techinique of physical therapy
Active Comparator: Hyperinflation (HMV)
Grup 2 - Hyperinflation with Mechanical ventilator: Is a physical therapy technique, that aims to clear the airways of patients on mechanical ventilation. Through the increase in inspiratory pressure ventilator .
Hyperinflation technique with mechanical ventilator which aims to clear the airways of patients on mechanical ventilation
Other Names:
  • Techinique of physical therapy
Experimental: HMV+VB
Grup 3 - Hyperinflation with mechanical ventilator and vibrocompression:Is a physical therapy technique, that aims to clear the airways of patients on mechanical ventilation. Through the thoracic compression during expiration and the increase in inspiratory pressure ventilator.
Association between Vibrocompression and Hyperinflation with mechanical ventilator
Other Names:
  • Techinique of physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Weight in grams of the pulmonary secretions
Time Frame: up to 24 weeks.
up to 24 weeks.

Secondary Outcome Measures

Outcome Measure
Time Frame
Time mechanical ventilator (MV) in days
Time Frame: Through study completion, an average of 3 years.
Through study completion, an average of 3 years.
Reintubation tracheal in percentage in the last 24 hours
Time Frame: Through study completion, an average of 3 years.
Through study completion, an average of 3 years.
Incidence of ventilator-associated pneumonia in percentage
Time Frame: Through study completion, an average of 3 years.
Through study completion, an average of 3 years.
Mortality in the MV in percentage
Time Frame: Through study completion, an average of 3 years.
Through study completion, an average of 3 years.
Heart Rate
Time Frame: up to 24 weeks.
up to 24 weeks.
Respiratory frequency
Time Frame: up to 24 weeks
up to 24 weeks
Peripheral oxygen saturation in percentage
Time Frame: up to 24 weeks
up to 24 weeks
Tidal volume in milliliters
Time Frame: up to 24 weeks
up to 24 weeks
Peak inspiratory pressure in centimeters of water
Time Frame: up to 24 weeks
up to 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Silvia R Rios Vieira, Dr, HCPorto Alegre, Rio Grande do Sul - Brazil

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

November 1, 2015

Study Registration Dates

First Submitted

November 6, 2015

First Submitted That Met QC Criteria

November 11, 2015

First Posted (Estimate)

November 13, 2015

Study Record Updates

Last Update Posted (Estimate)

November 13, 2015

Last Update Submitted That Met QC Criteria

November 11, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 11-0367

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Disability

Clinical Trials on Vibrocompression (VB)

3
Subscribe